Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating psoriasis patients with biologic agents

David M Pariser1

  • 1Department of Dermatology, Eastern Virginia Medical School, 601 Medical Tower, Norfolk, VA 23507, USA. dpariser@pariserderm.com

Managed Care (Langhorne, Pa.)
|January 16, 2004
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks.

American journal of clinical dermatology·2025
Same author

Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials.

Dermatology and therapy·2025
Same author

The enduring impact of the American Dermatological Association on US dermatology.

Journal of the American Academy of Dermatology·2025
Same author

Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study.

Journal of the American Academy of Dermatology·2025
Same author

Correction to: Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study.

Advances in therapy·2025
Same author

CT-P17 Adalimumab Biosimilar in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Open-Label Extension of a Phase 3 Interchangeability Study.

Dermatology and therapy·2025
Same journal

Thanks to CMS Rule Change, MA Takes SDOH to a Whole New Level.

Managed care (Langhorne, Pa.)·2019
Same journal

Hail, Not Frail! MA's Wellness Reach Expands.

Managed care (Langhorne, Pa.)·2019
Same journal

To Be Continued:The Search for a Cure for HIV.

Managed care (Langhorne, Pa.)·2019
Same journal

Once-a-day HIV Treatment: Pricey But Perhaps Worth It.

Managed care (Langhorne, Pa.)·2019
Same journal

In Trump, HIV/AIDS Groups Find an Ally Who's Tough To Love.

Managed care (Langhorne, Pa.)·2019
Same journal

Air Ambulance Turbulence: Consolidation, Cost Shifting, and Surprise Billing.

Managed care (Langhorne, Pa.)·2019
See all related articles